BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 25869100)

  • 41. Nuclear GSK-3beta inhibits the canonical Wnt signalling pathway in a beta-catenin phosphorylation-independent manner.
    Caspi M; Zilberberg A; Eldar-Finkelman H; Rosin-Arbesfeld R
    Oncogene; 2008 Jun; 27(25):3546-55. PubMed ID: 18223684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells.
    Vangamudi B; Zhu S; Soutto M; Belkhiri A; El-Rifai W
    Mol Cancer; 2011 Mar; 10():32. PubMed ID: 21447180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bisleuconothine A, a bisindole alkaloid, inhibits colorectal cancer cell in vitro and in vivo targeting Wnt signaling.
    Kong LM; Feng T; Wang YY; Li XY; Ye ZN; An T; Qing C; Luo XD; Li Y
    Oncotarget; 2016 Mar; 7(9):10203-14. PubMed ID: 26862734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
    Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
    Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling.
    Woods N; Trevino J; Coppola D; Chellappan S; Yang S; Padmanabhan J
    Oncotarget; 2015 Nov; 6(34):35931-48. PubMed ID: 26440150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit.
    Wang W; Yi M; Chen S; Li J; Zhang H; Xiong W; Li G; Li X; Xiang B
    J Cell Physiol; 2017 Oct; 232(10):2829-2840. PubMed ID: 27891591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. STMN2 is a novel target of beta-catenin/TCF-mediated transcription in human hepatoma cells.
    Lee HS; Lee DC; Park MH; Yang SJ; Lee JJ; Kim DM; Jang Y; Lee JH; Choi JY; Kang YK; Kim DI; Park KC; Kim SY; Yoo HS; Choi EJ; Yeom YI
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1059-67. PubMed ID: 16712787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer.
    Reabroi S; Chairoungdua A; Saeeng R; Kasemsuk T; Saengsawang W; Zhu W; Piyachaturawat P
    Biomed Pharmacother; 2018 May; 101():414-421. PubMed ID: 29501763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. WNT/β-catenin pathway is modulated in asthma patients and LPS-stimulated RAW264.7 macrophage cell line.
    Lee H; Bae S; Choi BW; Yoon Y
    Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):56-65. PubMed ID: 21699440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus.
    Dakeng S; Duangmano S; Jiratchariyakul W; U-Pratya Y; Bögler O; Patmasiriwat P
    J Cell Biochem; 2012 Jan; 113(1):49-60. PubMed ID: 21866566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adiponectin Suppresses Human Pancreatic Cancer Growth through Attenuating the β-Catenin Signaling Pathway.
    Jiang J; Fan Y; Zhang W; Shen Y; Liu T; Yao M; Gu J; Tu H; Gan Y
    Int J Biol Sci; 2019; 15(2):253-264. PubMed ID: 30745818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic targeting of casein kinase 1δ in breast cancer.
    Rosenberg LH; Lafitte M; Quereda V; Grant W; Chen W; Bibian M; Noguchi Y; Fallahi M; Yang C; Chang JC; Roush WR; Cleveland JL; Duckett DR
    Sci Transl Med; 2015 Dec; 7(318):318ra202. PubMed ID: 26676609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calcium sensing receptor suppresses human pancreatic tumorigenesis through a novel NCX1/Ca(2+)/β-catenin signaling pathway.
    Tang B; Chow JY; Dong TX; Yang SM; Lu DS; Carethers JM; Dong H
    Cancer Lett; 2016 Jul; 377(1):44-54. PubMed ID: 27108064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Silencing dishevelled-1 sensitizes paclitaxel-resistant human ovarian cancer cells via AKT/GSK-3β/β-catenin signalling.
    Zhang K; Song H; Yang P; Dai X; Li Y; Wang L; Du J; Pan K; Zhang T
    Cell Prolif; 2015 Apr; 48(2):249-58. PubMed ID: 25643607
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rac1b recruits Dishevelled and β-catenin to Wnt target gene promoters independent of Wnt3A stimulation.
    Pethe VV; Charames GS; Bapat B
    Int J Oncol; 2011 Oct; 39(4):805-10. PubMed ID: 21667018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate beta-catenin.
    Bryja V; Schulte G; Arenas E
    Cell Signal; 2007 Mar; 19(3):610-6. PubMed ID: 17027228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Docosahexaenoic acid promotes cell cycle arrest and decreases proliferation through WNT/β-catenin modulation in colorectal cancer cells exposed to γ-radiation.
    Murad LB; da Silva Nogueira P; de Araújo WM; Sousa-Squiavinato ACM; Rocha MR; de Souza WF; de-Freitas-Junior J; Barcellos-de-Souza P; Bastos LG; Morgado-Díaz JA
    Biofactors; 2019 Jan; 45(1):24-34. PubMed ID: 30521071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.